VTAK CATHETER PRECISION INC revenue, earnings and financials
For the quarter ended June 30, 2026, CATHETER PRECISION INC reported revenue of $1.02M (up 380.7% from a year earlier), net income of −$3.30M and diluted EPS of n/a; over the last four quarters revenue was $1.92M and net income −$13.0M; for the fiscal year ended December 2025 revenue was $819K, up 95.0% on the year before.
VTAK annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $819K, gross profit $756K, operating income −$21.1M, net income −$17.2M (margin -2098.0%), EPS n/a
- Fiscal year ended Dec 2024: revenue $420K, gross profit $378K, operating income −$11.2M, net income −$16.6M (margin -3962.6%), EPS n/a
- Fiscal year ended Dec 2023: revenue $442K, gross profit $412K, operating income −$78.1M, net income −$70.6M (margin -15966.5%), EPS n/a
- Fiscal year ended Dec 2022: revenue $14.0K, gross profit −$147K, operating income −$27.0M, net income −$26.9M (margin -191892.9%), EPS −$25.98
- Fiscal year ended Dec 2021: revenue $22.0K, gross profit −$1.54M, operating income −$29.3M, net income −$25.1M (margin -113954.5%), EPS −$248.22
VTAK quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.02M (up 380.7% year over year), net income −$3.30M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $432K (up 202.1% year over year), net income −$1.68M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $238K (up 59.7% year over year), net income −$5.78M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $226K (up 135.4% year over year), net income −$2.25M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $212K (up 128.0% year over year), net income −$5.11M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $143K (up 74.4% year over year), net income −$4.05M, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $149K (up 16.4% year over year), net income −$5.63M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $96.0K (down 27.8% year over year), net income −$4.12M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $93.0K (down 3.1% year over year), net income −$4.22M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $82.0K (down 3.5% year over year), net income −$2.68M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $128K, net income −$669K, EPS n/a
- Quarter ended Sep 30, 2023: revenue $133K, net income −$1.93M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $96.0K (up 1820.0% year over year), net income −$1.58M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $85.0K (up 844.4% year over year), net income −$66.4M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $0 (up 100.0% year over year), net income −$8.16M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $0 (down 100.0% year over year), net income −$4.76M, EPS −$4.36
- Quarter ended Jun 30, 2022: revenue $5.00K (down 99.5% year over year), net income −$8.45M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $9.00K (down 99.2% year over year), net income −$5.50M, EPS −$0.27
- Quarter ended Dec 31, 2021 (from the annual report): revenue −$2.11M, net income −$8.29M, EPS −$210.88
- Quarter ended Sep 30, 2021: revenue $5.00K, net income −$4.30M, EPS −$33.58
VTAK cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$8.30M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$9.27M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$20.6M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$22.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$27.6M, share buybacks n/a
VTAK balance sheet
- Jun 30, 2026: cash $643K, total assets $36.9M, total liabilities $19.7M, shareholders' equity $17.6M
- Mar 31, 2026: cash $441K, total assets $35.1M, total liabilities $25.9M, shareholders' equity $9.57M
- Dec 31, 2025: cash $88.0K, total assets $15.9M, total liabilities $9.21M, shareholders' equity $7.05M
- Sep 30, 2025: cash $1.08M, total assets $25.5M, total liabilities $19.0M, shareholders' equity $6.78M
- Jun 30, 2025: cash $838K, total assets $25.6M, total liabilities $19.0M, shareholders' equity $6.79M
- Mar 31, 2025: cash $450K, total assets $24.8M, total liabilities $16.9M, shareholders' equity $7.92M
- Dec 31, 2024: cash $2.87M, total assets $27.8M, total liabilities $16.0M, shareholders' equity $11.8M
- Sep 30, 2024: cash $1.27M, total assets $26.7M, total liabilities $13.9M, shareholders' equity $12.8M
What is VTAK's revenue?
CATHETER PRECISION INC reported $1.92M of revenue over its last four quarters, through June 30, 2026.
Is VTAK profitable?
No. CATHETER PRECISION INC lost $13.0M over the last four quarters.